The E2/E2 combination of ApoE isoforms is considered lower risk with a 0.6 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3).
the e2/e2 combination of apoe isoforms is considered lower risk with a 0.6 odds ratio for the development of alzheimer's disease versus the most common combination of apoe isoforms (e3/e3).
The E2/E2 combination of ApoE isoforms is considered lower risk with a 0.6 odds ratio for the development of Alzheimer's disease versus the most common combination of ApoE isoforms (E3/E3).
the e2/e2 combination of apoe isoforms is considered lower risk with a 0.6 odds ratio for the development of alzheimer's disease versus the most common combination of apoe isoforms (e3/e3).